Journals / Türk Hematoloji Onkoloji Dergisi / 2002 / Cilt: 12 - Sayı: 3

Melanozis sendromlu bir malign melanom olgusu

A malignant melanoma case with melanosis syndrome

Pages
162–165
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here we present a malignant melanoma case with melanosis syndrome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Malignant melanoma is a skin cancer usually cured by simple excision of the primary lesion, but nevertheless it is fatal in about one fifth of cases.
📊
Key Findings & Data:Gray-brown skin discoloration (melanosis syndrome) resulting from wide-spread melanoma can be seen, which causes high blood and urinary melanogens.
💡
Conclusion & Impact:Here we present a malignant melanoma case with melanosis syndrome.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Malignant melanoma is a skin cancer usually cured by simple excision of the primary lesion, but nevertheless it is fatal in about one fifth of cases. Gray-brown skin discoloration (melanosis syndrome) resulting from wide-spread melanoma can be seen, which causes high blood and urinary melanogens. Affected patients often have urine that is dark or darkens on exposure to air. Here we present a malignant melanoma case with melanosis syndrome.

Özet

Malign melanoma deri kanserlerinden birisidir. Genellikle primer lezyonun basit eksizyonuyla kür temin edilebilen bir kanser olmakla birlikte , vakaların beşte birinde ölümcüldür. Yaygın melanoma sonucu deride gri-kahverengi renk değişikliği (melanosis sendromu) görülebilir. Kanda ve idrarda melanojenlerde artış mevcuttur. Bu yazıda, melanosis sendromu ile birlikte olan bir malign melanoma olgusunu sunuyoruz.

🔖

Cite This Article

GÜLER, N., VARGEL, İ. (2022). Melanozis sendromlu bir malign melanom olgusu. Türk Hematoloji Onkoloji Dergisi, Cilt: 12 - Sayı: 3, 162–165. https://ajindex.com/articles/624762

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Lotze MT, Dallal RM, Kirkwood JM, Flickinger JC. Cutaneous melanoma. In: Cancer Princi- ples&Practice of Oncology, DeVita VT, Hell- man S, Rosenberg S A (eds): 6th ed. Philadel¬ phia, Lippincott-Raven Publishers, 2001: 2012- 2069
  2. Hegde U, Gause B. Skin cancer and melanoma. In: Bethesda Handbook of Clinical Oncology, Abraham J, Allegra CJ (eds). Philadelphia, Lip- pincott Williams & Wilkins, 2001: 249-268
  3. Eldar M, Weinberger A, Ben Bassat M, et al. Diffuse melanosis secondary to disseminated malignant melanoma. Cutis 25: 416, 1980
  4. Sexton M, Soyder CR. Generalized melanosis in occult primary melanoma. J Am Acad Dermatol 20: 261,1989
  5. Green RJ, Schuchter LM. Systemic treatment of metastatic melanoma with chemotherapy. Hematol Oncol Clin North Am 12: 863-874, 1998
  6. Byers HR, Bhawan J. Pathologic parameters in the diagnosis and prognosis of primary cuta¬ neous melanoma. Hematol Oncol Clin North Am 12: 717-728,1998
  7. Stadelrnann WK, Reintgen DS. Prognosis in malignant melanoma. Hematol Oncol Clin North Am 12: 767-796, 1998
  8. Atkins MB. The treatment of metastatic melanoma with chemotherapy and biologies. Curr Opin Oncol 9: 205-213, 1997.